You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 24, December 28, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Arrhythmias
 •Alert me on articles by topic

Prophylaxis Against Postoperative Atrial Fibrillation

Current Progress and Future Directions

Mihai V. Podgoreanu, MD; Joseph P. Mathew, MD

JAMA. 2005;294:3140-3142.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Atrial fibrillation is by far the most common complication following cardiac surgery, with an incidence consistently reported to range between 27% and 40% and with little change over the past 2 decades.1-5 Postoperative atrial fibrillation is associated with greater resource use as well as neurological, renal, and infectious complications.4 Patients with recurrent episodes of postoperative atrial fibrillation appear to be at the greatest risk for these adverse outcomes.4 Although atrial fibrillation is often less costly than other postsurgical complications, it is clear that the high rate of occurrence and recurrence places substantial financial and clinical burdens on clinicians and patients.2, 6

Many preoperative predictors of postoperative atrial fibrillation have been defined and include advanced age, a history of atrial fibrillation or chronic obstructive pulmonary disease, and valve replacement/repair surgery.2, 4-5 Advanced age has been the most consistent of these predictors with every 10-year increase . . . [Full Text of this Article]

Author Affiliations: Department of Anesthesiology, Duke University Medical Center, Durham, NC.


RELATED ARTICLE

Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: A Randomized Controlled Trial
L. Brent Mitchell, Derek V. Exner, D. George Wyse, Carol J. Connolly, Gregory D. Prystai, Alexander J. Bayes, William T. Kidd, Teresa Kieser, John J. Burgess, André Ferland, Charles L. MacAdams, and Andrew Maitland
JAMA. 2005;294(24):3093-3100.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.